These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa. Miller I, Lynggaard CD, Lophaven S, Zachariae C, Dufour DN, Jemec GB. Br J Dermatol; 2011 Aug; 165(2):391-8. PubMed ID: 21457202 [Abstract] [Full Text] [Related]
7. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis. Baumann L, Slezinger A, Halem M, Vujevich J, Martin LK, Black L, Bryde J. Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543 [Abstract] [Full Text] [Related]
8. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial. Mostafa TAH, Hamed AA, Mohammed BM, El Sheikh NA, Shama AAA. Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406 [Abstract] [Full Text] [Related]
10. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study. Campanati A, Penna L, Guzzo T, Menotta L, Silvestri B, Lagalla G, Gesuita R, Offidani A. Clin Ther; 2003 Jan; 25(1):298-308. PubMed ID: 12637128 [Abstract] [Full Text] [Related]
11. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study. Güleç AT. J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253 [Abstract] [Full Text] [Related]
13. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis. Odderson IR. Dermatol Surg; 2002 Jun; 28(6):480-3. PubMed ID: 12081675 [Abstract] [Full Text] [Related]
17. Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage. Campanati A, Martina E, Giuliodori K, Bobyr I, Consales V, Offidani A. Dermatol Ther; 2019 May; 32(3):e12841. PubMed ID: 30693648 [Abstract] [Full Text] [Related]